Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancer image analysis software to be tested:

This article was originally published in Clinica

Executive Summary

Confirma is to begin two clinical studies to assess its ACCENT data analysis software product that works with MRI to determine the extent of disease in cancer patients. The product, which is designed to provide information about both the location and volume of cancerous tumours, will be tested in patients with either breast or prostate cancer. The ACCENT system provides information that is critical to treatment planning and for following the progress of therapy, said the Kirkland, Washington-based company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel